SAL0137 Phase I Study in in Healthy Participants With or Without Elevated Lp(a)

NCT07745114 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

144

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants
Elevated Lp(a)

Interventions

DRUG: Single Ascending Dose
DRUG: Single Ascending Dose
DRUG: Once Daily (QD), Multiple Ascending Dose (MAD)
DRUG: Once Daily (QD), Multiple Ascending Dose (MAD)

Sponsor

Shenzhen Salubris Pharmaceuticals Co., Ltd.